Guru World

Neurocrine Adds to Pipeline With $2 Billion Takeda Deal

Biotech gets 7 drugs in partnership, 3 of which are in phase 2 testingRelated Stocks: NBIX, XENE, VYGR, TAKACAD, SAGE, ITCI,

Read more: gurufocus.com

Tags

Related Articles

Back to top button
Close
Close